B
Novo Nordisk A/S NVO
$141.55 -$0.53-0.37%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

03/31/2024 12/31/2023 09/30/2023 06/30/2023 03/31/2023
Revenue 9.52B 9.51B 8.58B 7.93B 7.69B
Total Other Revenue -- -- -- -- --
Total Revenue 9.52B 9.51B 8.58B 7.93B 7.69B
Cost of Revenue 1.44B 1.45B 1.42B 1.15B 1.18B
Gross Profit 8.07B 8.06B 7.16B 6.79B 6.51B
SG&A Expenses 2.10B 2.69B 2.06B 2.25B 1.94B
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses 82.70M -433.10K -14.31M 2.19M -4.75M
Total Operating Expenses 4.88B 5.44B 4.65B 4.44B 4.09B
Operating Income 4.64B 4.07B 3.93B 3.49B 3.60B
Income Before Tax 4.65B 3.99B 4.10B 3.54B 3.56B
Income Tax Expenses 948.04M 816.66M 815.64M 705.13M 709.33M
Earnings from Continuing Operations 3.70B 3.17B 3.28B 2.84B 2.85B
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 3.70B 3.17B 3.28B 2.84B 2.85B
EBIT 4.64B 4.07B 3.93B 3.49B 3.60B
EBITDA 5.06B 4.28B 4.30B 3.81B 3.85B
EPS Basic 0.83 0.71 0.73 0.63 0.63
Normalized Basic EPS 0.65 0.59 0.57 0.49 0.50
EPS Diluted 0.83 0.71 0.73 0.63 0.63
Normalized Diluted EPS 0.65 0.58 0.57 0.49 0.49
Average Basic Shares Outstanding 4.46B 4.46B 4.48B 4.49B 4.50B
Average Diluted Shares Outstanding 4.47B 4.48B 4.49B 4.50B 4.51B
Dividend Per Share -- 0.92 0.00 0.44 --
Payout Ratio 112.40% 0.00% 59.75% 0.00% 92.55%
Weiss Ratings